| Application no. and date | 09707396.9 (espacenet) (Federated) (European Patent Register), 20090206 | | Patent/reg. no. and date | DK/EP 2250279, 20160413 | | Publication date | 20101117 | | Priority no. and date | US 6962 P, 20080208, US 34618 P, 20080307, US 49970 P, 20080502 | | EP pub. no. and date |
EP 2250279 20101117 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | Medimmune IFNAR-110EP1 | | Inventor | COYLE, Anthony, 1155 23rd Street
Washington
DC 20037, US,
KIENER, Peter, 14017 Gorky Drive
Potomac
MD 20854, US,
WU, Herren, 14405 Havest Moon Road
Boyds
MD 20841, US,
CIBOTTI, Ricardo, 7102 Amy Lane
Bethesda
MD, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-IFNAR1-ANTISTOFFER MED REDUCERET FC-LIGANDAFFINITET | | Int. application no. | US2009033358 | | Int. publication no. | WO2009100309 | | Related patent (certificate) | CA 2022 00019 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
